Form 8-K - Current report:
SEC Accession No. 0001493152-24-039646
Filing Date
2024-10-07
Accepted
2024-10-07 08:10:19
Documents
18
Period of Report
2024-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46441
2 ex10-1.htm EX-10.1 1504
3 ex99-1.htm EX-99.1 13197
4 ex10-1_001.jpg GRAPHIC 365986
5 ex10-1_002.jpg GRAPHIC 233855
6 ex99-1_001.jpg GRAPHIC 64294
  Complete submission text file 0001493152-24-039646.txt   1158512

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE imnn-20241002.xsd EX-101.SCH 3009
8 XBRL LABEL FILE imnn-20241002_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE imnn-20241002_pre.xml EX-101.PRE 24161
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3688
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 241356209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)